Trademarkia Logo

Australia

AU$
NUVAXOVID
Protected: Registered/protected

Last updated on 16 May 2024

Owner Info

Novavax, Inc.

21 Firstfield Road

Gaithersburg MD 20878, UNITED STATES OF AMERICA

Serial Number

2246173 filed on 29 Nov 2021

Correspondent

Caroline L. Marsili

Carlson, Caspers, Vandenburgh & Lindquist, P.A.,,

225 South Sixth St., Suite 4200,

UNITED STATES OF AMERICA

NUVAXOVID

Classification Information


Class [005]
Vaccines for the treatment and prevention of Covid-19.

Class [042]
Providing medical and scientific research information in the field of Covid-19 vaccines, and clinical trials and post-market trials related to Covid-1 Read More

Mark Details


Serial Number

2246173

Registered On

29 Nov 2021

Renewal On

29 Nov 2031

Mark Type

FIGURATIVE

Priority Claim (Convention Details)


Date

6 Jul 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
16th May 2024Amendment to International Registration Contact Requested
21st Apr 2022International Registration in Australia Protected correspondence sent
20th Apr 2022IP Right Registration Published
20th Apr 2022Status change to Registered/Protected
10th Feb 2022Application Accepted correspondence sent
9th Feb 2022IP Right has been Examined
9th Feb 2022IP Right Acceptance Published
9th Feb 2022Status change to Accepted
8th Feb 2022Examination expedited
8th Feb 2022Awaiting examination